{"id":2132,"date":"2019-09-27T18:32:37","date_gmt":"2019-09-27T18:32:37","guid":{"rendered":"https:\/\/ring20researchsupport.co.uk\/?p=2132"},"modified":"2023-02-10T08:54:20","modified_gmt":"2023-02-10T08:54:20","slug":"crdn-raresummit19","status":"publish","type":"post","link":"https:\/\/ring20researchsupport.co.uk\/it\/2019\/09\/crdn-raresummit19\/","title":{"rendered":"CRDN RAREsummit19"},"content":{"rendered":"<p>\u00c8 stata una settimana estenuante ma esilarante, il momento clou \u00e8 stata la partecipazione <a href=\"https:\/\/camraredisease.org\/summit-2019\/\">RAREsummit19 <\/a>al <a href=\"https:\/\/www.wellcomegenomecampus.org\/\">Benvenuto Genome Campus<\/a> organizzato dal Cambridge Rare Disease Network luned\u00ec 23 settembre 19.<\/p>\n<p>Dalla presentazione del nostro ultimo poster sul nostro stand Ring20, alla presentazione a un auditorium gremito di 250 persone, ai numerosi contatti per il follow-up in termini di collaborazione futura - e per finire ho fatto il BBC News quella sera! (guarda il video:\u00a0<a href=\"https:\/\/ring20researchsupport.co.uk\/it\/cause\/ring20-in-the-news\/\">Video clip della BBC News<\/a>).<\/p>\n<p>Era un inizio presto, guidando fino a Cambridge dall&#039;Essex per arrivare alle 8 del mattino per affiggere il nostro nuovo poster e organizzare lo stand.<\/p>\n<p style=\"text-align: left;\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone size-medium wp-image-2136 alignright\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-300x245.jpg\" alt=\"IMG_4841\" width=\"300\" height=\"245\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-300x245.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-1024x835.jpg 1024w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-768x626.jpg 768w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-1536x1252.jpg 1536w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-2048x1670.jpg 2048w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-16x12.jpg 16w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-600x489.jpg 600w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p style=\"text-align: left;\">Il tema che abbiamo scelto per il nostro poster \u00e8 stato &quot;Risolvere il puzzle&quot; della diagnosi. La sindrome r (20) \u00e8 percepita come sottodiagnosticata e probabilmente mal diagnosticata. Una grande parte del problema \u00e8 la mancanza di consapevolezza tra pediatri e neurologi dei segni e sintomi di r (20) che sono molto simili ad altre epilessie rare come <a href=\"http:\/\/www.lgsfoundation.org.uk\/\">Sindrome di Lennox Gastaut<\/a> (LGS) a causa dell&#039;onda di picco lenta <span class='tooltipsall tooltipsincontent classtoolTips1'>EEG<\/span> modello e prolungato <a href=\"https:\/\/www.epilepsy.com\/learn\/professionals\/resource-library\/epilepsy-behavior-articles\/presentation-evaluation-and\">stato epilettico non convulsivo (NCSE)<\/a>. I test del pannello standard per l&#039;epilessia genetica NON rilevano attualmente l&#039;anello <span class='tooltipsall tooltipsincontent classtoolTips0'>cromosomi<\/span>, quindi, a meno che il medico curante non sappia di richiedere un cariotipo per testare il mosaicismo cromosomico (e di presentare almeno 50-100 cellule, che \u00e8 pi\u00f9 del normale inviato), le possibilit\u00e0 che venga fatta una diagnosi r(20) sono in realt\u00e0 molto magra. Sospettiamo che una percentuale di pazienti con altre diagnosi di epilessia, ad es. LGS, possa effettivamente avere r(20), ma non ha mai avuto i test diagnostici per dimostrarlo... SAPEVATE che anello <span class='tooltipsall tooltipsincontent classtoolTips0'>cromosomi<\/span> si verifica 1 su 50.000 nati vivi? Quindi, perch\u00e9 ci sono solo 150 casi di r(20) citati nella letteratura medica in tutto il mondo? Ci aspetteremmo molto di pi\u00f9...<\/p>\n<p><strong>Perch\u00e9 la diagnosi \u00e8 importante?<\/strong> La diagnosi pu\u00f2 portare a diverse opzioni di cura e trattamento. A livello molto attuale, al momento stiamo tutti sentendo parlare di Cannabidiolo (Epidyolex) nelle notizie che \u00e8 concesso in licenza negli Stati Uniti e che \u00e8 stato approvato proprio questa settimana dall&#039;EMA in Europa. Sebbene ogni paese europeo abbia ancora molta strada da fare per determinare se offrire Epidyolex nell&#039;ambito del proprio sistema sanitario nazionale, se e quando sar\u00e0 approvato per l&#039;uso sar\u00e0 inizialmente disponibile solo per coloro con una diagnosi di sindrome di Dravet o LGS come aggiunta -su Clobazam. Potrebbe passare un po &#039;di tempo prima che questo trattamento possa essere prescritto <em>off-labe<\/em>l ad altri pazienti con epilessia rara complessa come quelli con sindrome r (20) - e tuttavia condividiamo gli stessi sintomi di molti pazienti con LGS?<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-medium wp-image-2134 alignright\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4870-283x300.jpg\" alt=\"IMG_4870\" width=\"283\" height=\"300\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4870-283x300.jpg 283w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4870-965x1024.jpg 965w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4870-768x815.jpg 768w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4870-11x12.jpg 11w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4870-600x637.jpg 600w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4870.jpg 1286w\" sizes=\"(max-width: 283px) 100vw, 283px\" \/>Ho avuto il privilegio che mi sia stato offerto un posto nel panel dei pazienti, dando il via ai lavori principali della giornata. Nervoso, ma fiducioso nel mio argomento, sono salito sul palco e ho aspettato che il mio spazio parlasse. Il tema del pannello era <strong>Gruppi di pazienti che collaborano nel processo di sviluppo del farmaco. S<em>qualcosa per tutti?<\/em><\/strong> e il mio adorabile mentore <a href=\"http:\/\/www.draccon.com\/ana-mingorance\">Ana Mingorance<\/a> (nella foto qui) stava facilitando. Ana mi \u00e8 stata nominata da EURORDIS come parte del programma di leadership che sto seguendo quest&#039;anno e questo \u00e8 stato il primo incontro faccia a faccia per noi, Ana \u00e8 una neuroscienziata e ha un background che lavora nella scoperta e nello sviluppo di farmaci nel settore farmaceutico industria. Ha lavorato con il <a href=\"https:\/\/dravet.eu\/\">Fondazione Dravet<\/a> in Spagna e ora lavora con il <a href=\"https:\/\/www.louloufoundation.org\/\">Fondazione LouLou<\/a> (che rappresenta CDKL5 un&#039;altra rara epilessia).<\/p>\n<p>La mia presentazione era incentrata sul fatto che come gruppo di pazienti che rappresenta una malattia ultra-rara siamo all&#039;inizio del viaggio di sviluppo del farmaco - in effetti, abbiamo ancora molta strada da fare per muovere i primi passi poich\u00e9 abbiamo un numero limitato di no . di casi diagnosticati, nessun registro dei pazienti, pochissime ricerche, nessun biomarcatore e non sono mai stati coinvolti in una sperimentazione clinica. Tuttavia, capovolgo questo concetto e suggerisco che siamo maturi per l&#039;opportunit\u00e0! Ho spiegato che, anche come organizzazione di pazienti affetti da malattie ultra rare, possiamo ancora essere coinvolti e aumentare il profilo della malattia che rappresentiamo, che \u00e8 esattamente quello che ho fatto attraverso il mio impegno in <a href=\"https:\/\/epi-care.eu\/\">EpiCARE <\/a>il <a href=\"https:\/\/ec.europa.eu\/health\/ern_en\">Rete di riferimento europea (ERN)<\/a> per epilessie rare e complesse. Semplicemente partecipando alle discussioni ed essendo presente, r (20) viene ascoltato e riconosciuto e so per certo che nel normale Sistema di gestione del paziente clinico (<a href=\"https:\/\/epi-care.eu\/clinical-patient-management-system-cpms-live-12pm-cet-20th-november-2017\/\">CPMS) <\/a>sessioni - in cui i neurologi di tutta Europa discutono i casi pi\u00f9 complessi in una sessione di consultazione virtuale - recentemente sono stati suggeriti diversi casi per verificare una diagnosi di r (20). Anche se sono stati testati e non sono risultati r (20), \u00e8 un progresso! Stiamo anche lavorando a diverse iniziative per produrre materiali educativi per medici e famiglie di pazienti nell&#039;ambito di <a href=\"https:\/\/epi-care.eu\/\">EpiCARE <\/a>- questo non sarebbe successo se non fossi stato volontario per loro ...<\/p>\n<p>Eccolo presentando:<\/p>\n<div id='gallery-1' class='gallery galleryid-2132 gallery-columns-4 gallery-size-thumbnail'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/it\/img_4845\/'><img decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4845-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-1-2137\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4845-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4845-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4845-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-2137'>\n\t\t\t\tPannello paziente\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/it\/img_4848\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4848-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-1-2138\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4848-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4848-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4848-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-2138'>\n\t\t\t\tCondividi se sei ultra raro\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/it\/img_4851\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4851-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-1-2140\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4851-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4851-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4851-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-2140'>\n\t\t\t\tChi siamo\u2026\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/it\/img_4852\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4852-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-1-2141\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4852-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4852-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4852-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-2141'>\n\t\t\t\tInformazioni sulla sindrome r (20)\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n<p>Il mio discorso \u00e8 stato registrato, quindi lo condivider\u00f2 non appena sar\u00e0 disponibile.<\/p>\n<p>Subito dopo la mia presentazione \u00e8 stata una pausa caff\u00e8 tanto necessaria, tuttavia sono stato avvicinato immediatamente da due rappresentanti di <a href=\"https:\/\/www.illumina.com\/\"><strong>Illumina<\/strong> <\/a>(la societ\u00e0 dietro i supercomputer che sequenziano il genoma umano nel campus come parte del progetto 100.000 genomi). L&#039;interesse \u00e8 stato suscitato dal mio discorso e vogliono parlare di pi\u00f9 per vedere se possono aiutarci. Jillian Hastings-Ward Chair del Regno Unito <a href=\"https:\/\/www.genomicsengland.co.uk\/about-genomics-england\/the-100000-genomes-project\/\"><strong>#Genomes100k<\/strong><\/a> Il panel dei partecipanti \u00e8 spuntato dal mio stand anche per salutare - ci siamo incontrati un paio di mesi fa quando ho parlato l&#039;ultima volta al <strong>Sano Genetics<\/strong> evento. La successiva \u00e8 stata Mary Bythell, Responsabile della registrazione delle malattie rare del National Congenital Anomalies and Rare Disease Registry Service (<a href=\"https:\/\/www.gov.uk\/guidance\/the-national-congenital-anomaly-and-rare-disease-registration-service-ncardrs\"><strong>NCARDRS<\/strong><\/a>). Con cui eravamo gi\u00e0 stati in contatto <a href=\"https:\/\/www.gov.uk\/guidance\/the-national-congenital-anomaly-and-rare-disease-registration-service-ncardrs\"><strong>NCARDRS<\/strong> <\/a>e hanno scoperto che non avevano ancora alcuna registrazione di pazienti r (20), tuttavia ora sono interessati a parlarci di come possiamo cambiare questo e abbiamo gi\u00e0 programmato una chiamata per parlare dei prossimi passi.<br \/>\n<img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-2133 alignright\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/UK-Rare-Disease-Strategy-diagram-300x225.jpg\" alt=\"UK Rare Disease Strategy diagram\" width=\"300\" height=\"225\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/UK-Rare-Disease-Strategy-diagram-300x225.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/UK-Rare-Disease-Strategy-diagram-768x576.jpg 768w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/UK-Rare-Disease-Strategy-diagram-16x12.jpg 16w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/UK-Rare-Disease-Strategy-diagram-600x450.jpg 600w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/UK-Rare-Disease-Strategy-diagram.jpg 960w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>Per quelli di voi che non conoscono queste 3 organizzazioni, formano la triade di servizi nel Regno Unito creata come risultato del\u00a0<a href=\"https:\/\/www.gov.uk\/government\/publications\/uk-strategy-for-rare-diseases-2019-update-to-the-implementation-plan-for-england\"><strong>Strategia per le malattie rare del Regno Unito 2013-2020<\/strong><\/a>, che dovrebbe essere rinnovato a breve. Questi sono attori chiave nel sequenziamento \/ diagnosi genomica (in cui il Regno Unito \u00e8 leader mondiale), nella registrazione delle malattie rare e nell&#039;accesso alla ricerca per i pazienti affetti da malattie rare. Vogliamo davvero che r (20) sia nel loro radar e stiamo lavorando duramente per far s\u00ec che ci\u00f2 accada. (In effetti siamo anche in conversazione con <a href=\"https:\/\/bioresource.nihr.ac.uk\/rare-diseases\/rare-diseases\/\">NIHR Bioresource Unit<\/a> per determinare come potremmo ottenere una coorte di cromosomi r (20) \/ anello sui loro libri.)<\/p>\n<p>Nel pomeriggio siamo stati sfidati a partecipare a un hackathon presentato da <a href=\"https:\/\/www.gov.uk\/government\/people\/nicola-blackwood\">Baronessa Nicola Blackwood<\/a>, Sottosegretario di Stato parlamentare presso il Dipartimento della sanit\u00e0 e dell&#039;assistenza sociale. La baronessa Blackwood ha anche lei una malattia rara e quindi \u00e8 una sostenitrice positiva della nostra comunit\u00e0. Ci siamo divisi in gruppi per coprire diversi argomenti, tra cui diagnosi, coordinamento dell&#039;assistenza, accesso alla ricerca, costo del trattamento e responsabilizzazione del paziente. C&#039;\u00e8 stata una vivace discussione e io grido a gran voce per le malattie ultra-rare (inclusa r (20)) in cui semplicemente i bisogni di base devono essere soddisfatti per primi e che non dovrebbe essere compito delle piccole organizzazioni di pazienti `` al tavolo della cucina &#039;&#039; di finanziare queste attivit\u00e0 es. avere un registro dei pazienti in modo da sapere quante persone sono colpite e come possono essere contattate per la partecipazione alla ricerca. I risultati sono stati discussi come un intero gruppo e i temi chiave saranno scritti e presentati alla Baronessa Blackwood entro la fine dell&#039;anno, come input per la prossima Strategia per le malattie rare del Regno Unito. (Questo \u00e8 il terzo evento in cui ho contribuito a contribuire a questa strategia in una settimana, poich\u00e9 ho anche lavorato come parte del sottogruppo delle malattie rare per la Neurological Alliance e ho partecipato a un evento organizzato da Genetic Alliance UK , quindi come gruppo di pazienti stiamo decisamente dicendo la nostra e contribuendo ai risultati finali!)<\/p>\n<div id='gallery-2' class='gallery galleryid-2132 gallery-columns-3 gallery-size-thumbnail'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/it\/20190923_145704\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_145704-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-2-2163\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_145704-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_145704-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_145704-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-2-2163'>\n\t\t\t\tLa baronessa Blackwood presenta la sfida hackathon\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/it\/20190923_151726\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_151726-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_151726-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_151726-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_151726-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/it\/20190923_170521\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_170521-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-2-2161\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_170521-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_170521-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_170521-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-2-2161'>\n\t\t\t\tI risultati sono arrivati e la ricerca \u00e8 in cima all&#039;agenda\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n<p>C&#039;erano molti amici e conoscenti con cui mettersi al passo <a href=\"https:\/\/camraredisease.org\/summit-2019\/\"><strong>RAREsummit19<\/strong> \u00a0<\/a>Compreso <a href=\"https:\/\/www.rarerevolutionmagazine.com\/\"><strong>Rivoluzione rara<\/strong><\/a>, <a href=\"https:\/\/www.findacure.org.uk\/\"><strong>Findacure<\/strong><\/a>, <a href=\"https:\/\/www.akusociety.org\/\"><strong>AKU Society<\/strong><\/a>, compagno <a href=\"https:\/\/www.eurordis.org\/content\/epags\">EPAG <\/a>rappresentanti compresi da <a href=\"http:\/\/pitthopkins.org.uk\/\"><strong>Pitt Hopkins<\/strong><\/a>, Jelena Aleksic di\u00a0<strong><a href=\"https:\/\/www.sparkbio.it\/\">Sparkbio<\/a>, <\/strong>Patrick Short di <a href=\"https:\/\/sanogenetics.com\/\"><strong>Sano Genetics<\/strong><\/a>... l&#039;elenco potrebbe continuare. Anche se si dice che ci siano pi\u00f9 di 8.000 malattie rare, la comunit\u00e0 dei pazienti \u00e8 piuttosto unita e forte e ci sosteniamo a vicenda come una grande famiglia. Ron Jortner (da\u00a0<a href=\"https:\/\/www.masthead-biosciences.com\/\"><strong>Masthead Biosciences<\/strong><\/a> e fiduciario per <a href=\"https:\/\/camraredisease.org\/\">CRDN<\/a>) mi ha contattato di recente in merito a r (20) e ci ha inclusi in uno dei suoi discorsi: ora vorrebbe dare seguito a una potenziale opportunit\u00e0 per noi di presentare alle aziende farmaceutiche nel prossimo futuro.<\/p>\n<div id='gallery-3' class='gallery galleryid-2132 gallery-columns-3 gallery-size-thumbnail'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/it\/img_4866\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4866-e1569594361280-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-3-2144\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4866-e1569594361280-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4866-e1569594361280-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4866-e1569594361280-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-3-2144'>\n\t\t\t\tcon Jillian Hastings Ward\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/it\/img_4861\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4861-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-3-2142\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4861-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4861-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4861-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-3-2142'>\n\t\t\t\tIllumina\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/it\/img_4867\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4867-e1569594420384-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-3-2145\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4867-e1569594420384-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4867-e1569594420384-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4867-e1569594420384-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-3-2145'>\n\t\t\t\tRon Jortner\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n<p>Uno degli organizzatori, Joanna Segeith (da\u00a0<a href=\"http:\/\/biosynetix.co.uk\/\"><strong>Biosynetix<\/strong><\/a>) ci siamo messi in contatto prima dell&#039;evento e abbiamo avuto un breve dialogo durante la giornata. Joanna ha un&#039;idea per un&#039;opportunit\u00e0 di ricerca per prove di &quot;basket&quot; e parleremo con la professoressa Helen Cross su come noi tre potremmo portare avanti questa idea.<\/p>\n<p><strong>Il solo fatto di uscire e parlare della sindrome r (20) ci fa davvero notare.\u00a0<\/strong>Magari la prossima volta qualcuno di voi si unir\u00e0 a me, il vostro supporto mi sarebbe davvero utile \ud83d\ude09<\/p>\n<p>Potresti pensare che molte delle opportunit\u00e0 di questo evento siano basate nel Regno Unito, ma dobbiamo fare piccoli passi e iniziare da qualche parte. Il mio lavoro con <a href=\"https:\/\/epi-care.eu\/\">EpiCARE <\/a>significa che stiamo lavorando anche a livello europeo. Prossima tappa per conquistare il mondo - un passo alla volta ... eh?<\/p>\n<p>Ti terr\u00f2 aggiornato su eventuali sviluppi.\u00a0<strong>Questo \u00e8 davvero il luogo in cui avviene la magia!<\/strong><\/p>\n<script type=\"text\/javascript\"> toolTips('.classtoolTips0','Chromosomes are long string-like structures that store all of our DNA. Each cell in the human body usually has 23 pairs of chromosomes (or 46 chromosomes in total).'); <\/script><script type=\"text\/javascript\"> toolTips('.classtoolTips1','Electroencephalography'); <\/script>","protected":false},"excerpt":{"rendered":"<p>\u00c8 stata una settimana faticosa ma esaltante, il momento clou \u00e8 stato la partecipazione a RAREsummit19 al Wellcome Genome Campus organizzato dal Cambridge Rare Disease Network luned\u00ec 23 settembre 19.<\/p>","protected":false},"author":3,"featured_media":1254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[42],"tags":[],"class_list":["post-2132","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CRDN RAREsummit19 - Ring20 Research and Support UK CIO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ring20researchsupport.co.uk\/it\/2019\/09\/crdn-raresummit19\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CRDN RAREsummit19 - Ring20 Research and Support UK CIO\" \/>\n<meta property=\"og:description\" content=\"Its been and exhausting but exhilarating week, the highlight being attending RAREsummit19 at the Wellcome Genome Campus organised by the Cambridge Rare Disease Network on Monday 23rd Sept 19.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ring20researchsupport.co.uk\/it\/2019\/09\/crdn-raresummit19\/\" \/>\n<meta property=\"og:site_name\" content=\"Ring20 Research and Support UK CIO\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-27T18:32:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-10T08:54:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2014\/12\/600x450-r20-hoodie-front-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Alison\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alison\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/\"},\"author\":{\"name\":\"Alison\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/person\\\/26816b7c1c7561b936befe247794dcac\"},\"headline\":\"CRDN RAREsummit19\",\"datePublished\":\"2019-09-27T18:32:37+00:00\",\"dateModified\":\"2023-02-10T08:54:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/\"},\"wordCount\":1572,\"publisher\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2014\\\/12\\\/600x450-r20-hoodie-front-logo.jpg\",\"articleSection\":[\"Events\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/\",\"name\":\"CRDN RAREsummit19 - Ring20 Research and Support UK CIO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2014\\\/12\\\/600x450-r20-hoodie-front-logo.jpg\",\"datePublished\":\"2019-09-27T18:32:37+00:00\",\"dateModified\":\"2023-02-10T08:54:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2014\\\/12\\\/600x450-r20-hoodie-front-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2014\\\/12\\\/600x450-r20-hoodie-front-logo.jpg\",\"width\":600,\"height\":450,\"caption\":\"Hoodie - logo close up\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CRDN RAREsummit19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#website\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/\",\"name\":\"Ring20 Research and Support UK CIO\",\"description\":\"Promoting research, education and continuous support to end undiagnosed and misdiagnosed Ring20 epilepsy\",\"publisher\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#organization\",\"name\":\"Ring20 Research and Support CIO\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Ring20_logo-high-resolution.jpg\",\"contentUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Ring20_logo-high-resolution.jpg\",\"width\":2357,\"height\":666,\"caption\":\"Ring20 Research and Support CIO\"},\"image\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/person\\\/26816b7c1c7561b936befe247794dcac\",\"name\":\"Alison\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g\",\"caption\":\"Alison\"},\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/it\\\/author\\\/alison\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CRDN RAREsummit19 - Ring20 Research and Support UK CIO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ring20researchsupport.co.uk\/it\/2019\/09\/crdn-raresummit19\/","og_locale":"it_IT","og_type":"article","og_title":"CRDN RAREsummit19 - Ring20 Research and Support UK CIO","og_description":"Its been and exhausting but exhilarating week, the highlight being attending RAREsummit19 at the Wellcome Genome Campus organised by the Cambridge Rare Disease Network on Monday 23rd Sept 19.","og_url":"https:\/\/ring20researchsupport.co.uk\/it\/2019\/09\/crdn-raresummit19\/","og_site_name":"Ring20 Research and Support UK CIO","article_published_time":"2019-09-27T18:32:37+00:00","article_modified_time":"2023-02-10T08:54:20+00:00","og_image":[{"width":600,"height":450,"url":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2014\/12\/600x450-r20-hoodie-front-logo.jpg","type":"image\/jpeg"}],"author":"Alison","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"Alison","Tempo di lettura stimato":"8 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/#article","isPartOf":{"@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/"},"author":{"name":"Alison","@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/person\/26816b7c1c7561b936befe247794dcac"},"headline":"CRDN RAREsummit19","datePublished":"2019-09-27T18:32:37+00:00","dateModified":"2023-02-10T08:54:20+00:00","mainEntityOfPage":{"@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/"},"wordCount":1572,"publisher":{"@id":"https:\/\/ring20researchsupport.co.uk\/#organization"},"image":{"@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/#primaryimage"},"thumbnailUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2014\/12\/600x450-r20-hoodie-front-logo.jpg","articleSection":["Events"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/","url":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/","name":"CRDN RAREsummit19 - Ring20 Research and Support UK CIO","isPartOf":{"@id":"https:\/\/ring20researchsupport.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/#primaryimage"},"image":{"@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/#primaryimage"},"thumbnailUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2014\/12\/600x450-r20-hoodie-front-logo.jpg","datePublished":"2019-09-27T18:32:37+00:00","dateModified":"2023-02-10T08:54:20+00:00","breadcrumb":{"@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/#primaryimage","url":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2014\/12\/600x450-r20-hoodie-front-logo.jpg","contentUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2014\/12\/600x450-r20-hoodie-front-logo.jpg","width":600,"height":450,"caption":"Hoodie - logo close up"},{"@type":"BreadcrumbList","@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ring20researchsupport.co.uk\/"},{"@type":"ListItem","position":2,"name":"CRDN RAREsummit19"}]},{"@type":"WebSite","@id":"https:\/\/ring20researchsupport.co.uk\/#website","url":"https:\/\/ring20researchsupport.co.uk\/","name":"Ring20 Research and Support UK CIO","description":"Promuovere la ricerca, l&#039;istruzione e il supporto continuo per porre fine all&#039;epilessia Ring20 non diagnosticata e mal diagnosticata","publisher":{"@id":"https:\/\/ring20researchsupport.co.uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ring20researchsupport.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/ring20researchsupport.co.uk\/#organization","name":"CIO di ricerca e supporto Ring20","url":"https:\/\/ring20researchsupport.co.uk\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/logo\/image\/","url":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/03\/Ring20_logo-high-resolution.jpg","contentUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/03\/Ring20_logo-high-resolution.jpg","width":2357,"height":666,"caption":"Ring20 Research and Support CIO"},"image":{"@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/person\/26816b7c1c7561b936befe247794dcac","name":"Alison","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g","caption":"Alison"},"url":"https:\/\/ring20researchsupport.co.uk\/it\/author\/alison\/"}]}},"_links":{"self":[{"href":"https:\/\/ring20researchsupport.co.uk\/it\/wp-json\/wp\/v2\/posts\/2132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ring20researchsupport.co.uk\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ring20researchsupport.co.uk\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/it\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/it\/wp-json\/wp\/v2\/comments?post=2132"}],"version-history":[{"count":1,"href":"https:\/\/ring20researchsupport.co.uk\/it\/wp-json\/wp\/v2\/posts\/2132\/revisions"}],"predecessor-version":[{"id":10384,"href":"https:\/\/ring20researchsupport.co.uk\/it\/wp-json\/wp\/v2\/posts\/2132\/revisions\/10384"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/it\/wp-json\/wp\/v2\/media\/1254"}],"wp:attachment":[{"href":"https:\/\/ring20researchsupport.co.uk\/it\/wp-json\/wp\/v2\/media?parent=2132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/it\/wp-json\/wp\/v2\/categories?post=2132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/it\/wp-json\/wp\/v2\/tags?post=2132"}],"curies":[{"name":"parola chiave","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}